Amarin Corporation
AMRN
#7883
Rank
NZ$0.56 B
Marketcap
NZ$26.99
Share price
-1.64%
Change (1 day)
47.26%
Change (1 year)

Earnings for Amarin Corporation (AMRN)

Earnings in 2025 (TTM): -NZ$0.15 Billion

According to Amarin Corporation 's latest financial reports the company's current earnings are NZ$0.22 Billion. In 2024 the company made an earning of -NZ$0.14 Billion a decrease over its 2023 earnings that were of -NZ$93.11 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Amarin Corporation from 1994 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.15 Billion10.97%
2024 -NZ$0.14 Billion43.84%
2023 -NZ$93.11 Million-48.3%
2022 -NZ$0.19 Billion-1019.36%
2021 NZ$19.58 M-165.44%
2020 -NZ$29.94 Million-23.25%
2019 -NZ$39 Million-80.68%
2018 -NZ$0.21 Billion112.25%
2017 -NZ$95.1 Million-28.23%
2016 -NZ$0.14 Billion-35.43%
2015 -NZ$0.21 Billion99.81%
2014 -NZ$0.11 Billion-65.06%
2013 -NZ$0.3 Billion-0.38%
2012 -NZ$0.3 Billion-150.87%
2011 NZ$0.57 B-233.68%
2010 -NZ$0.44 Billion
2007 -NZ$67.72 Million44.04%
2006 -NZ$47.02 Million
2004 -NZ$25.41 Million-46.41%
2003 -NZ$47.4 Million-41.09%
2002 -NZ$80.46 Million813.31%
2001 -NZ$8.81 Million113.63%
2000 -NZ$4.13 Million
1998 -NZ$29.32 Million98.82%
1997 -NZ$14.75 Million-50.29%
1996 -NZ$29.67 Million-1321.43%
1995 NZ$2.42 M-94.53%
1994 NZ$44.4 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AbbVie
ABBV
NZ$2.87 B-2,050.60%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$22.70 B-15,481.54%๐Ÿ‡ฌ๐Ÿ‡ง UK
Alkermes
ALKS
NZ$0.70 B-576.62%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
GlaxoSmithKline
GSK
NZ$16.17 B-11,054.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$3.07 B-2,182.21%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel